Emerging research suggests that certain cannabinoids, like THCV , may actually support glucose regulation and improve insulin sensitivity, potentially acting in synergy with metabolic treatments
With studies characterising reduced infarct size, improved cardiac function, promotion of cardiac progenitor cell migration, cardiomyocyte survival through PI3K/Akt anti-apoptotic signalling, and stimulation of new vessel formation in infarcted myocardium
*Correspondence: Amin Talebi Bezmin Abadi, [email protected] This article was submitted to Gastrointestinal and Hepatic Pharmacology, a section of the journal Frontiers in Pharmacology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
These changes happen slowly and are often connected to better health overall
The bigger picture for midlife health Inflammation in perimenopause matters well beyond the scales